Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Hits New 52-Week High – Here’s What Happened

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) shares reached a new 52-week high on Friday . The company traded as high as $9.84 and last traded at $9.65, with a volume of 32902 shares. The stock had previously closed at $9.61.

Wall Street Analyst Weigh In

Separately, Citigroup raised shares of Fresenius SE & Co. KGaA to a “strong-buy” rating in a research note on Friday, October 25th.

Fresenius SE & Co. KGaA Stock Performance

The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.05. The company has a 50-day moving average price of $8.93 and a 200-day moving average price of $8.97.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last issued its earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share (EPS) for the quarter. The company had revenue of $5.90 billion for the quarter. Analysts forecast that Fresenius SE & Co. KGaA will post 0.79 EPS for the current fiscal year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.